FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is a nootropic agent prepared of an inorganic (mineral) raw material. A formulation with the following proportion of the ingredients is used as the above agent, wt %: potassium chloride 98.5-78.3, magnesium sulphate 0.98-20.8, zinc sulphate 0.42-0.65 and rubidium nitrate 0.1-0.25.
EFFECT: positive effect of the nootropic agent simulated and studied in rodents, enables extending the range of product possessing nootropic activity with high specific action: enhanced exploratory activity and manifested antineurotic reaction; the agent has no effect on motor activity.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
PSYCHOSTIMULANT AGENT | 2010 |
|
RU2438677C1 |
PREPARATION POSSESSING NOOTROPIC ACTION | 2014 |
|
RU2568843C1 |
NOOTROPIC AGENT POSSESSING ANTI-HYPOXIC ACTIVITY | 2006 |
|
RU2314115C1 |
AGENT POSSESSING NOOTROPIC AND ADAPTOGENIC ACTIVITY | 2006 |
|
RU2311193C1 |
DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
COMPOSITION HAVING ACTION ON CENTRAL NERVOUS SYSTEM AND USING IT | 2013 |
|
RU2546300C1 |
COLLECTION OF MEDICINAL PLANTS OF NOOTROPIC ACTION | 2015 |
|
RU2578453C1 |
4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
Authors
Dates
2013-09-27—Published
2012-07-04—Filed